Bradleys Galer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Zogenix : Amendment to Annual Report (Form 10-K/A)

10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM . | March 7, 2022

United statesUnited kingdomRedwood cityResearch triangle parkNorth carolinaSan diegoSyracuse universityDistrict of columbiaSan franciscoUniversity of southern californiaNew jerseyNew yorkUniversity of arizonaRutgers universityStanford universityDana farber cancer institute

Zogenix To Present New FINTEPLA® (fenfluramine) Data at AES

Data add to the growing body of evidence supporting the efficacy and safety profile of FINTEPLA for the treatment of Dravet syndrome.

United statesPorter novelliTrish mccallTevard biosciencesBradleys galerBrian ritchieUs securities exchange commissionLifesci advisorsAmerican epilepsy societyEuropean commissionDrug administrationEuropean early access programEuropean medicines agencyAnnual meetingBetter outcomes through diversityExecutive vice president

Zogenix Launches Global Access Program for FINTEPLA® (Fenfluramine) Oral Solution

Zogenix Launches Global Access Program for FINTEPLA® (Fenfluramine) Oral Solution
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Melinda bakerDan piggottTevard biosciencesBradleys galerUs securities exchange commissionZogenix access programEuropean commissionUniphar group product access divisionUs food drug administrationZogenix launches global access programCorporate communicationsEuropean unionEuropean medicines agencyAccess programOral solutionExecutive vice president